Muscarinic agonists to treat impulse control disorders

Details for Australian Patent Application No. 2007247231 (hide)

Owner Solvay Pharmaceuticals B.V.

Inventors Kruse, Cornelis G.; De Bruin, Natasja M.W.J.; Herremans, Arnoldus H.J.; Tulp, Martinus Th.m.; Van Drimmelen, Marlies L.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2007247231

PCT Pub. Number WO2007/128674

Priority 06113476.3 04.05.06 EP; 60/797,355 04.05.06 US

Filing date 23 April 2007

Wipo publication date 15 November 2007

Acceptance publication date 31 May 2012

International Classifications

A61K 31/00 (2006.01)

A61K 31/439 (2006.01) - the ring forming part of a bridged ring system, e.g. quinuclidine

A61K 31/4439 (2006.01)

A61K 31/551 (2006.01) - having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

Event Publications

27 November 2008 PCT application entered the National Phase

  PCT publication WO2007/128674 Priority application(s): WO2007/128674

31 May 2012 Application Accepted

  Published as AU-B-2007247231

11 October 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007247242-Selection of host cells expressing protein at high levels

2007247223-Titanium catalyst, its preparation and its use in epoxidation reactions